Skip to content

Validation of the Utility of Ophthalmology Intelligent Diagnostic System

Validation of the Utility of Ophthalmology Intelligent Diagnostic System: A Clinical Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03499145
Enrollment
615
Registered
2018-04-17
Start date
2018-04-01
Completion date
2019-08-31
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Ophthalmopathy

Keywords

conjunctivitis, keratitis, pterygium, cataracts

Brief summary

The prevention and treatment of diseases via artificial intelligence represents an ultimate goal in computational medicine. Application scenarios of the current medical algorithms are too simple to be generally applied to real-world complex clinical settings. Here, the investigators use deep learning and visionome technique, an novel annotation method for artificial intelligence in medical, to create an automatic detection and classification system for four key clinical scenarios: 1) mass screening, 2) comprehensive clinical triage, 3) hyperfine diagnostic assessment, and 4) multi-path treatment planning. The investigator also establish a telemedicine system and conduct clinical trial and website-based study to validate its versatility.

Interventions

DEVICEOphthalmology diagnostic system.

An artificial intelligence to make comprehensive evaluation and treatment decision of ocular diseases.

Sponsors

Ministry of Health, China
CollaboratorOTHER_GOV
Xidian University
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients and residents who underwent ophthalmic examination of the eye and recorded their ocular information in the outpatient clinic and community.

Design outcomes

Primary

MeasureTime frame
The proportion of accurate, mistaken and miss detection of the ophthalmology diagnostic system.Up to 5 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026